MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeffery, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeffery, E. H.

The effect of zinc on NADPH oxidation and monooxygenase activity in rat hepatic microsomes

EH Jeffery

This study confirms that zinc is able to inhibit hepatic microsomal drug metabolism and the related oxidation of NADPH. Zinc activates microsomal pyrophosphatase, a zinc-containing enzyme capable of metabolizing both NADPH and NADH. Although this reaction produces a potent inhibitor of drug metabolism, 2',5'-ADP', the activation of pyrophosphatase by zinc was found not to be solely responsible for the zinc-dependent inhibition of drug metabolism. Zinc was seen to inhibit drug metabolism in the presence of 5'-AMP, which inhibits pyrophosphatase. Incubation of zinc with microsomes prior to the addition of NADPH caused an interaction between zinc and the microsomal enzymes that was not reversed by NADPH. Zinc was found to exhibit noncompetitive inhibition of cytochrome c reduction and mixed inhibition of drug metabolism, with respect to NADPH. Zinc inhibition of drug metabolism was noncompetitive with drug substrate. Zinc was found to interact with cytochrome P-450, decreasing its ability to bind to both drugs and carbon monoxide. Zinc had a far greater effect on the reduction of cytochrome P-450 (90% inhibited) than on the reduction of exogenous cytochrome c (20% inhibited), although the same reductase is responsible for both reactions. It is concluded that zinc inhibits drug metabolism either by alteration of the oxidation-reduction potential of the flavoprotein or by interacting with a flavoprotein/cytochrome P-450 complex.

Volume 23, Issue 2, pp. 467-473, 03/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Physiol. GenomicsHome page
I. Dozmorov, M. R. Saban, N. P. Gerard, B. Lu, N.-B. Nguyen, M. Centola, and R. Saban
Neurokinin 1 receptors and neprilysin modulation of mouse bladder gene regulation
Physiol Genomics, February 6, 2003; 12(3): 239 - 250.
[Abstract] [Full Text] [PDF]

Home page
 J Exp BotHome page
M. F. Quartacci, E. Cosi, and F. Navari-Izzo
Lipids and NADPH-dependent superoxide production in plasma membrane vesicles from roots of wheat grown under copper deficiency or excess
J. Exp. Bot., January 1, 2001; 52(354): 77 - 84.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics